Vectura Group
From Infogalactic: the planetary knowledge core
| 150px | |
| Public (LSE: VEC) | |
| Industry | Pharmaceuticals |
| Founded | 1999 |
| Headquarters | Chippenham, UK |
|
Key people
|
Bruno Angelici, Chairman Christopher Blackwell, (CEO) |
| Revenue | £58.0 million (2015)[1] |
| £(7.0) million (2015)[1] | |
| £3.7 million (2015)[1] | |
| Website | www.vectura.com |
Vectura Group plc (LSE: VEC) is a British-based pharmaceuticals business. It is based in Chippenham and is a constituent of the FTSE 250 Index.
History
The company was formed in 1999 as a start-up pharmaceuticals business.[2] In 1999 it acquired Co-ordinated Drug Development and the Centre for Drug Formulation Studies.[2] In 2004 it was listed on the Alternative Investment Market.[2] In 2007 it acquired Innovata plc, another developer of pulmonary products,[3] and then moved on the full list of the London Stock Exchange.[2] It acquired Activaero, a German manufacturer in the same sector, for £108 million in March 2014.[4]
Operations
The Group is a developer of inhaled therapies for the treatment of respiratory diseases.[5]
References
- ↑ 1.0 1.1 1.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 2.2 2.3 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Vectura buys Innovata Guardian, 17 November 2006
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
|
